Rare Disease Screening Firm 3billion Closes $13M Series C Financing
The Korean molecular diagnostics firm, a spinoff from genomic services provider Macrogen
Korean Rare Disease Diagnostics Firm 3billion Raises $10M
The company was originally founded as a spinoff from Korean genomic services provider Macrogen to offer direct-to-consumer genomic rare disease screening tests.
IncellDx Inks Chinese Collaboration, Distribution Agreements
As part of the agreement, Kindstar will use InCellDx's single-cell immuno-oncology and oncology diagnostic products in China, including Hong Kong and Macao.